Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
06/2009
06/02/2009US7541362 7-(3,4-Dichlorophenyl)-4,7-dihydro-5-methyl-6-(5-phenyl-2-oxazolyl)pyrazolo[1, 5-a]pyrimidine
06/02/2009US7541339 Par-2-activating peptide derivative and pharmaceutical composition using the same
06/02/2009US7541031 Methods for treating rheumatoid arthritis using human antibodies that bind human TNFα
06/02/2009US7541018 Treatment process using somatostatin analogues
06/02/2009CA2516433C Ramosetron hydrochloride for diarrhea-predominant irritable bowel syndrome
06/02/2009CA2349633C A process for producing particles with a converted amorphous and/or meta-stable crystalline region into crystalline state
06/02/2009CA2321664C Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
06/02/2009CA2226548C Lyophilized hepatocyte growth factor preparations
05/2009
05/28/2009WO2009067296A1 Treatment of oral pharyngeal dysphagia
05/28/2009WO2009067191A2 Methods and compositions for the treatment of hepatitis c virus (hcv) infection
05/28/2009WO2009066775A1 Amorphous form of heterocyclic compound, solid dispersion and medicinal preparation each comprising the same, and process for production of the same
05/28/2009WO2009066537A1 Immunoregulatory function inducer and food composition
05/28/2009WO2009066117A1 Use of edta and its derivatives for prevention and treatment of bacterial intestinal diseases of pigs and for increasing the effects of antibiotics exerted in such diseases
05/28/2009WO2009065946A2 Pharmaceutical kit consisting of an oil-in-water emulsion and a solid composition
05/28/2009WO2009045313A3 Oxypiperidine derivatives as histamine receptor antagonists
05/28/2009WO2009010968A3 Disease treatment via antimicrobial peptides or their inhibitors
05/28/2009WO2008068615A8 Crystalline forms of ( 3 s ) -3- [n- (n' - (2-tert-butylphenyl) oxamyl) alaninyl] amino-5- (2 ', 3 ', 5 ', 6 ' -tetrafluoro phenoxy) -4-0x0penta noic acid
05/28/2009US20090137845 Novel 4-Dedimethylaminotetracycline derivatives
05/28/2009US20090137685 Therapeutic Agent for Inflammatory Bowel Disease Containing as Active Ingredient 2-Amino-1,3-Propanediol Derivative, or Method for Treating Inflammatory Bowel Disease
05/28/2009US20090137633 Stable pharmaceutical composition of rabeprazole
05/28/2009US20090137623 Muscarinic receptor antagonists
05/28/2009US20090137604 corticotropin releasing factor receptor antagonists such as 8-(N-butyl-N-(2-butynyl)amino)-2-methyl-3-(2-chloro-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine, used for the treatment of nervous system, psychological, eating, sleep, and gastrointestinal disorders
05/28/2009US20090137602 Combination preparation against vertigo
05/28/2009US20090137586 Compounds for the treatment of inflammatory disorders
05/28/2009US20090137526 Purification Method for Biomaterial
05/28/2009US20090137513 RNA Interference Mediated Inhibition of Acetyl-CoA-Carboxylase Gene Expression Using Short Interfering Nucleic Acid (siNA)
05/28/2009US20090137512 nucleotide sequence complementary to a target RNA sequence and a second sequence chemically modified so it can no longer act as a guide sequence for mediating RNA interference, having complementarity to said first sequence; cancer, proliferative diseases
05/28/2009US20090137511 RNA INTERFERENCE MEDIATED INHIBITION OF PLACENTAL GROWTH FACTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
05/28/2009US20090137509 RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATION CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
05/28/2009US20090137508 Treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability
05/28/2009US20090137482 Biologically active peptide and agent containing the same
05/28/2009US20090137459 Food Product for Enteral or Oral Nutrition
05/28/2009US20090136588 Methods For Altering Food Intake, Modifying Nutrient Digestibility and Altering Stool Quality and/or Stool Frequency
05/28/2009US20090136508 Method of diagnosing colon and gastric cancers
05/28/2009US20090136473 Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders
05/28/2009US20090136432 Oral Stannous Compositions
05/28/2009DE102007056424A1 Pharmazeutische Zusammensetzung, enthaltend eine Öl/Wasser-Emulsion A pharmaceutical composition containing an oil / water emulsion
05/28/2009DE102007056253A1 Use of homogenized sloe composition, obtained by heating, e.g. for liquefaction of body fluids, reduction of surface tension, for the reduction of body odor, preferably excrement and sweat, to promote hair growth and as antibiotic
05/28/2009CA2706536A1 Amorphous body composed of heterocyclic compound, solid dispersion and pharmaceutical preparation each comprising the same, and process for production of the same
05/28/2009CA2706391A1 Spiropiperidines for use as tryptase inhibitors
05/28/2009CA2705836A1 Treatment of oral pharyngeal dysphagia
05/27/2009EP2062914A2 Somatostatin-dopamine chimeric analogs
05/27/2009EP2062879A1 Heterocyclic inhibitors of p38
05/27/2009EP2062878A1 Hydrazine amide derivative
05/27/2009EP2062595A1 Inhibition of inflammation using alpha 7 receptor-binding cholinergic agonists
05/27/2009EP2062584A1 Adhesive preparation
05/27/2009EP2062583A2 Therapeutic applications of pro-apoptotic benzodiazepines
05/27/2009EP2062579A1 Solid pharmaceutical composition for oral administration comprising optically stable ramosetron
05/27/2009EP2062577A1 Oleanolic acid derivatives as NO production inhibitors
05/27/2009EP2061484A2 Treatment, prevention, and reversal of alcohol-induced liver disease
05/27/2009EP2061483A1 Oral polymeric membrane feruloyl esterase producing bacteria formulation
05/27/2009EP2061463A1 Topical composition comprising a dihydropyridine calcium antagonist
05/27/2009EP2061443A2 Polyconjugates for in vivo delivery of polynucleotides
05/27/2009EP1519915B1 Tricyclic steroid hormone nuclear receptor modulators
05/27/2009EP1366075B1 New interferon beta-like molecules
05/27/2009EP1351672B1 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders
05/27/2009EP1292678B1 G-protein coupled receptors
05/27/2009EP1244448B1 Novel methods for the treatment and prevention of ileus
05/27/2009CN101443322A Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
05/27/2009CN101443041A Method and means for treating inflammatory bowel disease
05/27/2009CN101443019A Use of cholest-4-in-3-in-one derivatives to obtain a cytoprotective medicine
05/27/2009CN101443009A Antitumor agent for thyroid cancer
05/27/2009CN101442990A New form of administration of racecadotril
05/27/2009CN101442985A Parenteral formulation comprising proton pump inhibitor sterilized in its final container by ionizing radiation
05/27/2009CN101440116A Glycyrrhizin, preparation and use thereof
05/27/2009CN101440113A Colchicine derivative-bile acid coupling compounds and medical use thereof
05/27/2009CN101439187A Novel coupling compound of bile acid and anti-hepatitis virus medicament and medical use thereof
05/27/2009CN101439181A Stable water injection medicament composition containing Ulinastatin
05/27/2009CN101439180A Medicament composition for improving stability of Ulinastatin
05/27/2009CN101439179A Chinese medicine health-care decoction for pancreatic gland
05/27/2009CN101439176A Chinese medicine pills for treating acute cholecystitis
05/27/2009CN101439172A Chinese medicinal composition and preparation method thereof and quality control method
05/27/2009CN101439170A Chinese medicine prescription for treating ulcerative colitis
05/27/2009CN101439169A Chinese medicinal composition for treating stomach-ache
05/27/2009CN101439164A Method for preparing Chinese medicine for treating sthenia fire type aphtha
05/27/2009CN101439155A Chinese herbal medicine composition for treating vertigo disease
05/27/2009CN101439153A Production of tonic wine
05/27/2009CN101439150A Chinese medicinal composition for treating intestinal inflammation
05/27/2009CN101439149A Chinese medicinal composition for treating gastric ulcer, gastrorrhagia and gastric perforation
05/27/2009CN101439137A External-use Chinese medicinal composition for toothache
05/27/2009CN101439122A Chinese medicine granule containing prepared rehmannia root extract and preparation method thereof
05/27/2009CN101439117A Chinese medicine for treating enterospasm of children
05/27/2009CN101439109A Chinese herbal medicinal composition for treating enterogastric disease and preparation method and use
05/27/2009CN101439092A Navel paste for treating diarrhea, enuresis, night sweat and spontaneous perspiration, and preparation method thereof
05/27/2009CN101439085A Chinese medicine granule containing agastache extract and preparation method thereof
05/27/2009CN101439084A Chinese medicine granule containing agastache extract and preparation method thereof
05/27/2009CN101439074A Rhizoma atractylodis total terpene alcohol extract as well as preparation method and application thereof
05/27/2009CN101439070A Chinese medicine for treating enterogastric disease
05/27/2009CN101439068A Chinese medicine granule containing silymarin and preparation method thereof
05/27/2009CN101439035A Novel use of tea polyphenol
05/27/2009CN101439025A Silymarin high-efficient long-acting preparation and production method thereof
05/27/2009CN101439018A Silybin compound emulsion for intravenous injection and preparation method thereof
05/27/2009CN101438748A Liver-protecting tea and preparation method thereof
05/27/2009CN100491523C Two kinds of lactic acid bacteria , and method for using it to prepare purgative ecological oral liquid
05/27/2009CN100491376C Method of extracting deydrokaividing and solubilizing injection agent from rock gold thread total alkaloid
05/27/2009CN100491374C 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as C-KIT inhibitors
05/27/2009CN100491368C Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
05/27/2009CN100491353C Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor
05/27/2009CN100491336C Novel derivatives of 3,3-diphenylpropylamines
05/27/2009CN100490893C Osteogenic composition